Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05962489 · ClinicalTrials.gov registry record · NA
Sleep-specific DBS Therapy in Parkinson's Disease
A NA study of Dystonia and Deep Brain Stimulation, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT05962489: Recruiting NA study of Dystonia and Deep Brain Stimulation, sponsored by University of Minnesota.
NCT05962489 is a NA study of Dystonia and Deep Brain Stimulation that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 64 participants, below the 538-participant average among 28 other Dystonia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05962489, a NA study of Dystonia and Deep Brain Stimulation, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
Sleep-wake disturbances are a major factor associated with reduced quality of life of individuals with Parkinson's disease (PD), a progressive neurological disorder affecting millions of people in the U.S and worldwide. The brain mechanisms underlying these sleep disorders, and the effects of therapeutic interventions such as deep brain stimulation on sleep-related neuronal activity and sleep behavior, are not well understood. Results from this study will provide a better understanding of the brain circuitry involved in disordered sleep in PD and inform the development of targeted therapeutic interventions to treat sleep disorders in people with neurodegenerative disease.
Primary Outcome
Percent of pallidopeduncular and pedunculopallidal pathway activation
Conditions Studied
Interventions
- OTHER Clinically optimized deep brain stimulation
Study Locations (1)
Minnesota
- University Of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2023-06-22 |
| Est. Completion | 2027-08-01 |
| Phase | NA |
What NCT05962489 shows while recruiting
NCT05962489 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 538-participant average among 28 other Dystonia trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Dystonia appearing as the primary indexed condition, and to 1 intervention - of which Clinically optimized deep brain stimulation is the first listed.
NCT05962489 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05962489 about?
NCT05962489 is a clinical study titled "Sleep-specific DBS Therapy in Parkinson's Disease". Sleep-wake disturbances are a major factor associated with reduced quality of life of individuals with Parkinson's disease (PD), a progressive neurological disorder affecting millions of people in the U.S and worldwide. The brain mechanisms underlying these sleep disorders, and the effects of therap...
What is the current status of trial NCT05962489?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2023-06-22. Estimated completion is 2027-08-01.
What conditions does trial NCT05962489 study?
This clinical trial studies the following conditions: Dystonia, Deep Brain Stimulation, Parkinson's Disease and Parkinsonism.
What interventions are being tested in trial NCT05962489?
The interventions under investigation include: Clinically optimized deep brain stimulation (OTHER).
Who is sponsoring clinical trial NCT05962489?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05962489 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dystonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05962489's enrollment target sits among peer trials
64 17th of 28 higher than 12 of 28 other Dystonia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dystonia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Exercise on Dystonia Pathophysiology
RECRUITING · NA
-
Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia
RECRUITING · NA
-
Deep Brain Stimulation Surgery for Movement Disorders
RECRUITING · NA
-
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
RECRUITING · NA
-
Cortical-Basal Ganglia Speech Networks
RECRUITING · NA
-
Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI